MyD88-dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons

Souvenir D Tachado1, Xin Li, Medhavi Bole

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. stachado@bidmc.harvard.edu

Blood
|March 4, 2010
PubMed

Insights

HIV impairs a specific part of macrophage Toll-like receptor 4 (TLR4) signaling, affecting defense against bacterial pneumonia. This targeted disruption impacts MyD88-dependent pathways while sparing others.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cell Biology

Background:

  • Alveolar macrophages (AMs) are key lung immune cells, using Toll-like receptor 4 (TLR4) for pathogen defense.
  • HIV infection is known to impair macrophage function, but specific signaling defects remain unclear.

Purpose of the Study:

  • To investigate whether HIV impairs myeloid differentiation factor 88 (MyD88)-dependent and/or MyD-independent TLR4 signaling pathways in human macrophages.
  • To compare TLR4 signaling in HIV-infected U1 macrophages versus healthy U937 macrophages and in clinical samples.

Main Methods:

  • Utilized human U937 and HIV-infected U1 macrophage cell lines.
  • Analyzed key signaling events including protein interactions, phosphorylation, and nuclear translocation.
  • Assessed responses in alveolar macrophages from healthy and HIV-infected individuals.

Main Results:

  • HIV infection specifically impairs the MyD88-dependent TLR4 pathway, evidenced by reduced MyD88-IRAK interaction, IRAK phosphorylation, and NF-kappaB translocation.
  • TNFalpha release is significantly reduced in HIV-infected macrophages via the MyD88-dependent pathway.
  • The MyD88-independent TLR4 pathway, including STAT1 phosphorylation and IL-10/RANTES release, remains largely preserved.
  • Similar impairment patterns were observed in alveolar macrophages from HIV-positive individuals.

Conclusions:

  • Chronic HIV infection selectively disrupts the MyD88-dependent TLR4 signaling pathway in macrophages.
  • This targeted impairment may contribute to the increased susceptibility to bacterial pneumonia seen in HIV patients.
  • Understanding this specific defect offers insights into HIV-associated immune dysfunction and potential therapeutic targets.